Literature DB >> 12504932

A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation.

.   

Abstract

OBJECTIVES: To compare the effect of delivering early to pre-empt terminal hypoxaemia with delaying for as long as possible to increase maturity.
DESIGN: A randomized controlled trial.
SETTING: 69 hospitals in 13 European countries. PARTICIPANTS: Pregnant women with fetal compromise between 24 and 36 weeks, an umbilical artery Doppler waveform recorded and clinical uncertainty whether immediate delivery was indicated.
METHODS: The interventions were 'immediate delivery' or 'delay until the obstetrician is no longer uncertain'. The data monitoring and analysis were Bayesian. MAIN OUTCOME MEASURES: 'Survival to hospital discharge' and 'developmental quotient at two years of age', this latter to be reported later.
RESULTS: Of 548 women (588 babies) recruited, outcomes were available on 547 mothers (587 babies). The median time-to-delivery intervals were 0.9 days in the immediate group and 4.9 days in the delay group. Total deaths prior to discharge were 29 (10%) in the immediate group versus 27 (9%) in the delay group (odds ratio 1.1, 95% CI 0.61-1.8). Total caesarean sections were 249 (91%) in the immediate group versus 217 (79%) in the delay group: (OR 2.7; 95% CI 1.6-4.5). These odds ratios were similar for those randomized at gestational ages above or below 30 weeks.
INTERPRETATION: The lack of difference in overall mortality suggests that clinicians participating in this trial were on average prepared to randomize at about the correct equivocal threshold between delivery and delay. However, there was insufficient evidence to convince enthusiasts for either immediate or delayed delivery that they were wrong.

Entities:  

Mesh:

Year:  2003        PMID: 12504932     DOI: 10.1016/s1470-0328(02)02514-4

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  42 in total

1.  Plato's Socratic dialogues and the epistemology of modern medicine.

Authors:  James May; Michael Baum; Susan Bewley
Journal:  J R Soc Med       Date:  2010-12       Impact factor: 5.344

2.  Estrogen receptor-β and fetoplacental endothelial prostanoid biosynthesis: a link to clinically demonstrated fetal growth restriction.

Authors:  Emily J Su; Linda Ernst; Nadine Abdallah; Robert Chatterton; Hong Xin; Diana Monsivais; John Coon; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

3.  Intermediate Diastolic Velocity as a Parameter of Cardiac Dysfunction in Growth-Restricted Fetuses.

Authors:  Xiangna Tang; Edgar Hernandez-Andrade; Hyunyoung Ahn; Maynor Garcia; Homam Saker; Steven J Korzeniewski; Adi L Tarca; Lami Yeo; Sonia S Hassan; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2015-08-12       Impact factor: 2.587

Review 4.  Feeding growth restricted preterm infants with abnormal antenatal Doppler results.

Authors:  J Dorling; S Kempley; A Leaf
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09       Impact factor: 5.747

Review 5.  Management of fetal growth restriction.

Authors:  M Alberry; P Soothill
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01       Impact factor: 5.747

Review 6.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Gillian M L Gyte
Journal:  Cochrane Database Syst Rev       Date:  2013-11-12

Review 7.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2017-06-13

Review 8.  Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.

Authors:  Sarah J Stock; Leanne Bricker; Jane E Norman; Helen M West
Journal:  Cochrane Database Syst Rev       Date:  2016-07-12

9.  Impaired fetoplacental angiogenesis in growth-restricted fetuses with abnormal umbilical artery doppler velocimetry is mediated by aryl hydrocarbon receptor nuclear translocator (ARNT).

Authors:  Emily J Su; Hong Xin; Ping Yin; Matthew Dyson; John Coon; Kathryn N Farrow; Karen K Mestan; Linda M Ernst
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

10.  Overexpression of the aryl hydrocarbon receptor nuclear translocator partially rescues fetoplacental angiogenesis in severe fetal growth restriction.

Authors:  Shuhan Ji; Hong Xin; Emily J Su
Journal:  Clin Sci (Lond)       Date:  2019-06-20       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.